feed,title,long_url,short_url
SeekingAlpha,Arrowhead says phase 3 trial of rare metabolic disease asset plozasiran meets goals,https://seekingalpha.com/news/4112378,
SeekingAlpha,Energy stocks sink as OPEC+ plans to begin phasing out voluntary cuts this year,https://seekingalpha.com/news/4112381,
SeekingAlpha,Broadcom: Recent Pullback Makes It A Compelling Opportunity,https://seekingalpha.com/article/4697164,
